ClinicalTrials.gg
RecruitingNCT07358598Updated Oct 15, 2026

Eye Movement Parameters and Cognitive Functions in Older Adults

An observational study in Cognitive Dysfunction, sponsored by National Sun Yat-sen University. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by National Sun Yat-sen University · Observational

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.
Updated Oct 15, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
210
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 111 studies in Cognitive Dysfunction with a site in Taiwan — 24 open to participants now, 29 under way, 3 of them phase 3. Cognitive Dysfunction · Taiwan.

Planned enrollment
6th of 17
210 · median 192
Started
2026
with 4 others
Observational
17 of 111
6 open now
Primary completion
2026-12
later than 13 of 28 live
Registered
104th of 111
by date

Among the 111 studies in Cognitive Dysfunction with a site in Taiwan, this one is the 6th largest by planned enrollment of the 17 observational ones that give a count, is one of 5 that started in 2026, is one of 17 observational ones, reaches primary completion later than 13 of the 28 other live ones, and was the 104th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

24 of the 111 studies in Cognitive Dysfunction with a site in Taiwan are open now. Recruiting first, the newest first:

18 more — sign in →

All 24 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 111 studies in Cognitive Dysfunction with a site in Taiwan, or all of them as a file.
02

Study summary

Dementia most commonly occurs in elderly individuals, but currently there is still a lack of objective measurement methods that can detect cognitive impairment in older adults at an early stage. Eye movement is considered a clinical indicator with potential for screening mild cognitive dysfunction, and eye movement signals can be extracted to objectively evaluate cognition. Eye tracking has been used mostly to evaluate patients with neurodegenerative diseases such as Parkinson's disease. However, less attention has been paid to the relationship between eye movement and cognitive function in elderly individuals, as well as the association between eye movement data and abnormal cognitive subdomains. This cross-sectional study will recruit 0204 elderly individuals over the age of 65, divided into three groups (healthy group/mild cognitive impairment group/dementia group) according to the purpose of this study. Participants who have not been diagnosed with neurological diseases (such as Parkinson's disease or stroke), or have mental illness or visual impairments will be excluded. This study hopes to provide empirical data on eye movement signals and cognitive function in healthy older individuals, as well as to serve as a preliminary study for future development of eye activity stimulation to improve cognitive function in older adults.

03

Conditions studied

  • Cognitive Dysfunction

Keywords

  • Eye movements
  • Cognitive function impairment
  • Older adults
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

A total of 210 participants will be recruited, with an estimated 70 individuals in each cognitive group.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Participants are aged 65 years or older and have completed a comprehensive geriatric assessment (CGA) in the outpatient clinic.

Exclusion criteria

Exclusion Criteria:

  • Participants are under 65 years of age or those who ar are unable to comply with study procedures.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
210 participants (estimated)
Target follow-up
1 Year
Patient registry
Yes

Groups and cohorts

  • Healthy group-patients with intact cognitive function
  • Mild cognitive impairment group-patients with mild cognitive impairment
  • Dementia group-patients with severe cognitive impairment
06

What researchers measure

Primary outcomes

  1. Eye-tracking measurement

    Eye movement behavior will be assessed as an objective measure of cognitive control in older adults. Eye-tracking data will be collected using the J7EF Gaze Smart Glasses (Jorjin Technologies), a non-invasive wearable eye-tracking system with a sampling frequency of 30 Hz. Participants will perform standardized visual tasks while eye movement behavior is recorded. Outcome measures will include task-related eye movement patterns, such as gaze behavior and saccadic performance, which reflect attentional control and higher-order cognitive processing. Alterations in these eye movement parameters have been associated with cognitive impairment. Eye movement measures will be used to characterize differences in cognitive function across participant groups.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

Secondary outcomes

  1. Mini-Mental State Examination (MMSE)

    The Mini-Mental State Examination (MMSE) is a widely used cognitive screening tool originally developed by Folstein and McHugh in 1975 (Folstein et al., 1975). It consists of 30 items assessing six domains of cognitive function: orientation, attention, memory, language, verbal comprehension, praxis, and constructional ability. Higher scores indicate better cognitive function. A total score between 24 and 30 suggests intact cognitive function; scores between 18 and 23 are indicative of mild cognitive impairment; and scores from 0 to 17 reflect moderate to severe cognitive impairment. In the present study, the MMSE is used to classify adults aged 65 years and older into cognitive status groups, including a cognitively healthy group, a mild cognitive impairment (MCI) group, and a dementia group, based on established score thresholds.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

Other outcomes

  1. Eye-Tracking Task 1: Horizontal Fixation Task (HFT)

    The FXS task is designed to measure fixation stability. Participants are instructed to fixate on a white dot, that appears sequentially at different screen locations: initially in the center, then alternately to the left and right sides of the screen.Each position is maintained for 5 seconds, during which participants are instructed to maintain their gaze on the white dot. The sequence proceeds as follows: Center (5 seconds), right side (5 seconds), left side (5 seconds), and return to center (5 seconds). The task duration is approximately 20 seconds.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

  2. Eye-Tracking Task 2: Vertical Fixation Task (VFT)

    The Vertical Fixation Task is designed to assess vertical saccadic eye movements and fixation stability. A white fixation dot is sequentially displayed on a black background at specific vertical locations. The target is presented at the center of the screen and then alternates between upper and lower positions at 5-second intervals (center-upper-lower-center), with a total task duration of approximately 20 seconds.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

  3. Eye-tracking Task 3: Horizontal Pursuit Task (HPT)

    The HPT is designed to evaluate participants' ability to perform smooth horizontal pursuit eye movements. A white dot then appears at the center of a black screen, prompting participants to fixate and track the dot continuously as it begins moving horizontally. The stimulus moves smoothly and repeatedly from left to right and back across the screen. Participants are instructed to visually follow the moving dot toward to left and right side without shifting their head position. The task duration is approximately 30 seconds.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

  4. Eye-Tracking Task 4: Vertical Pursuit Task (VPT)

    The VPT is designed to evaluate participants' ability to perform smooth horizontal pursuit eye movements. A white dot then appears at the center of a black screen, prompting participants to fixate and track the dot continuously as it begins moving vertically. The stimulus moves smoothly and repeatedly from up to down across the screen. Participants are instructed to visually follow the moving dot toward to up and down side without shifting their head position. The task duration is approximately 30 seconds.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

  5. Eye-Tracking Task 5: Horizontal Saccade Task (HST)

    The HST is designed to evaluate rapid, reflexive saccadic eye movements in response to abrupt horizontal target shifts. A white fixation dot appears at the center of the screen and then jumps alternately between the far left and far right positions. Participants are instructed to track the dot continuously from left to right for the entire duration of the task (approximately 30 seconds). Each positional shift is abrupt, requiring quick and accurate horizontal saccades.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

  6. Eye-Tracking Task 6: Vertical Saccade Task (VST)

    The VST is designed to evaluate rapid, reflexive saccadic eye movements in response to abrupt horizontal target shifts. A white fixation dot appears at the center of the screen and then jumps alternately between the far up and far down positions. Participants are instructed to track the dot continuously from up to down for the entire duration of the task (approximately 30 seconds). Each positional shift is abrupt, requiring quick and accurate horizontal saccades.

    Time frame: A single assessment is conducted at one study visit (cross-sectional design).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Pereira ML, Camargo Mv, Aprahamian I, Forlenza OV. Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer's disease. Neuropsychiatr Dis Treat. 2014 Jul 9;10:1273-85. doi: 10.2147/NDT.S55371. eCollection 2014. PubMed 25031536 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 5, 2026
First posted
Jan 22, 2026
StartActual
Jan 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 15, 2026
Sites
Kaohsiung Veterans General Hospital is now Recruiting
Oct 15, 2026
Start date
Jan 17, 2026→Jan 1, 2026 (actual)
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Not yet recruiting→Recruiting
    Kaohsiung Veterans General Hospital is now Recruiting
    Start date Jan 17, 2026→Jan 1, 2026 (now actual)
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07358598
Lead sponsor
National Sun Yat-sen University
Responsible party
Sponsor
First posted
Jan 22, 2026
Start date
Jan 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 15, 2026

Study contacts

Yen Chin CHEN, Associated professor
Contact
yenchin2427@gmail.com
+886 7 5252000#7374

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion